中国医药科学Issue(4)：52-53,62,3.
缬沙坦治疗原发性高血压伴高尿酸血症的临床观察
Clinical observation of valsartan in the treatment of essential hypertension associated with hyperuricemia
张金春1
作者信息
- 1. 辽宁省普兰店市中心医院心血管二病房，辽宁普兰店116200
- 折叠
摘要
Abstract
Objective To investigate the efficacy of valsartan in the treatment of essential hypertension associated with hyperuricemia. Methods 120 cases of elderly patients with essential hypertension associated with hyperuricemia were randomly divided into experimental group and control group, each group contained 60 cases. The treatment group was given valsartan, and the control group was given extended release nifedipine tablets. The effects of two groups were compared. Results After treatment, the SBP and DBP of two groups patients were decreased significantly(P<0.05). The blood pressures of two groups were decreased to normal, without significant difference between two groups (P>0.05). The uric acid of experimental group was (491.03±73.57)μmol/L before treatment, and that was (385.71±34.28)μmol/L a f t e r t r e a t m e n t . The concentration of the blood uric acid of experimental group was decreased significantly (P < 0.05). In extended release nifedipine tablets group, the concentration of uric acid was no difference before and after treatment. Conclusion The valsartan in treatment of essential hypertension associated with hyperuricemia has obvious curative effect. It is safety, lasting effect, and worthy of clinical application.关键词
原发性高血压/高尿酸血症/氯沙坦Key words
Essential hypertension/Hyperuricemia/Valsartan分类
医药卫生引用本文复制引用
张金春..缬沙坦治疗原发性高血压伴高尿酸血症的临床观察[J].中国医药科学,2015,(4):52-53,62,3.
